Chi Phí Điều Trị và Sử Dụng Dịch Vụ Chăm Sóc Thực Tế ở Bệnh Nhân Bị Rối Loạn Trầm Cảm Chính Với và Không Có Các Bệnh Tâm Thần Kèm Theo Trong Chăm Sóc Tâm Thần Chuyên Khoa

GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1789-1858 de Graaf R, ten Have M, van Gool C, van Dorsselaer S. Prevalence of mental disorders and trends from 1996 to 2009. Results from the Netherlands Mental Health Survey and Incidence Study-2. Soc Psychiatry Psychiatr Epidemiol. 2012;47:203-213 Bromet E, Andrade LH, Hwang I, Sampson NA, Alonso J, de Girolamo G, de Graaf R, Demyttenaere K, Hu C, Iwata N, Karam AN, Kaur J, Kostyuchenko S, Lepine JP, Levinson D, Matschinger H, Mora ME, Browne MO, Posada-Villa J, Viana MC, Williams DR, Kessler RC. Cross-national epidemiology of DSM-IV major depressive episode. BMC Med. 2011;9:90-7015-9-90 Wells KB, Stewart A, Hays RD, Burnam MA, Rogers W, Daniels M, Berry S, Greenfield S, Ware J. The functioning and well-being of depressed patients: results from the Medical Outcomes Study. JAMA. 1989;262:914–9. Broadhead WE, Blazer DG, George LK, Tse CK. Depression, disability days, and days lost from work in a prospective epidemiologic survey. JAMA. 1990;264:2524–8. Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2197–223. Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386:743-800 Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3:e442. Maj M, Veltro F, Pirozzi R, Lobrace S, Magliano L. Pattern of recurrence of illness after recovery from an episode of major depression: a prospective study. Am J Psychiatry. 1992;149:795–800. Hardeveld F, Spijker J, De Graaf R, Nolen WA, Beekman AT. Prevalence and predictors of recurrence of major depressive disorder in the adult population. Acta Psychiatr Scand. 2010;122:184–91. Verhaak PF, Prins MA, Spreeuwenberg P, Draisma S, van Balkom TJ, Bensing JM, Laurant MG, van Marwijk HW, van der Meer K, Penninx BW. Receiving treatment for common mental disorders. Gen Hosp Psychiatry. 2009;31:46–55. National Institute for Public Health and the Environment (Rijksinstituut voor Volksgezondheid en Milieu (RIVM)). In: Volksgezondheidenzorg.info - Cost of Illness database 2017. statline.rivm.nl. Accessed July 2020. Kessler RC, Nelson CB, McGonagle KA, Liu J, Swartz M, Blazer DG. Comorbidity of DSM-III-R major depressive disorder in the general population: results from the US National Comorbidity Survey. Br J Psychiatry Suppl. 1996;30:17–30. Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, Rush AJ, Walters EE, Wang PS, National Comorbidity Survey Replication. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003;289:3095-3105 Keitner GI, Ryan CE, Miller IW, Kohn R, Epstein NB. 12-Month outcome of patients with major depression and comorbid psychiatric or medical illness (compound depression). Am J Psychiatry. 1991;148:345–50. Friborg O, Martinsen EW, Martinussen M, Kaiser S, Overgård KT, Rosenvinge JH. Comorbidity of personality disorders in mood disorders: a meta-analytic review of 122 studies from 1988 to 2010. J Affect Disord. 2014;152–154:1–11. Newton-Howes G, Tyrer P, Johnson T. Personality disorder and the outcome of depression: meta-analysis of published studies. Br J Psychiatry. 2006;188:13–20. Newton-Howes G, Tyrer P, Johnson T, Mulder R, Kool S, Dekker J, Schoevers R. Influence of personality on the outcome of treatment in depression: systematic review and meta-analysis. J Pers Disord. 2014;28:577–93. Patience DA, McGuire RJ, Scott AI, Freeman CP. The Edinburgh Primary Care Depression Study: personality disorder and outcome. Br J Psychiatry. 1995;167:324–30. De Bolle M, De Fruyt F, Quilty LC, Rolland JP, Decuyper M, Bagby RM. Does personality disorder co-morbidity impact treatment outcome for patients with major depression? A multi-level analysis. J Pers Disord. 2011;25:1–15. Koppers D, Kool M, Van H, Driessen E, Peen J, Dekker J. The effect of comorbid personality disorder on depression outcome after short-term psychotherapy in a randomised clinical trial. BJPsych Open. 2019;5:e61. Bender DS, Dolan RT, Skodol AE, Sanislow CA, Dyck IR, McGlashan TH, Shea MT, Zanarini MC, Oldham JM, Gunderson JG. Treatment utilization by patients with personality disorders. Am J Psychiatry. 2001;158:295–302. Wiegand HF, Godemann F. Increased treatment complexity for major depressive disorder for inpatients with comorbid personality disorder. Psychiatr Serv. 2017;68:524–7. Black DW, Bell S, Hulbert J, Nasrallah A. The importance of Axis II in patients with major depression. A controlled study J Affect Disord. 1988;14:115–22. Greenberg PE, Kessler RC, Birnbaum HG, Leong SA, Lowe SW, Berglund PA, Corey-Lisle PK. The economic burden of depression in the United States: how did it change between 1990 and 2000? J Clin Psychiatry. 2003;64:1465–75. Tomonaga Y, Haettenschwiler J, Hatzinger M, Holsboer-Trachsler E, Rufer M, Hepp U, Szucs TD. The economic burden of depression in Switzerland. Pharmacoeconomics. 2013;31:237–50. Luppa M, Heinrich S, Angermeyer MC, König H, Riedel-Heller SG. Cost-of-illness studies of depression: a systematic review. J Affect Disord. 2007;98:29–43. Thomas CM, Morris S. Cost of depression among adults in England in 2000. Br J Psychiatry. 2003;183:514–9. Kleine-Budde K, Muller R, Kawohl W, Bramesfeld A, Moock J, Rossler W. The cost of depression - a cost analysis from a large database. J Affect Disord. 2013;147:137–43. Konig H, Konig HH, Konnopka A. The excess costs of depression: a systematic review and meta-analysis. Epidemiol Psychiatr Sci. 2019;29:e30. Simon G, Ormel J, VonKorff M, Barlow W. Health care costs associated with depressive and anxiety disorders in primary care. Am J Psychiatry. 1995;152:352. Bosmans JE, de Bruijne MC, de Boer MR, van Hout H, van Steenwijk P, van Tulder MW. Health care costs of depression in primary care patients in The Netherlands. Fam Pract. 2010;27:542–8. Le TK, Curtis B, Kahle-Wrobleski K, Johnston J, Haldane D, Melfi C. Treatment patterns and resource use among patients with comorbid diabetes mellitus and major depressive disorder. J Med Econ. 2011;14:440–7. Mausbach BT, Bos T, Irwin SA. Mental health treatment dose and annual healthcare costs in patients with cancer and major depressive disorder. Health Psychol. 2018;37:1035–40. Wagner CJ, Metzger FG, Sievers C, Marschall U, L'hoest H, Stollenwerk B, Stock S. Depression-related treatment and costs in Germany: Do they change with comorbidity? A claims data analysis. J Affect Disord. 2016;193:257-266 Cuijpers P, Smit F, Penninx BW, de Graaf R, ten Have M, Beekman AT. Economic costs of neuroticism: a population-based study. Arch Gen Psychiatry. 2010;67:1086–93. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). 4th edn. Washington DC;1994 Hakkaart-van Roijen L, Van der Linden N, Bouwmans C, Kanters T, Tan SS. Kostenhandleiding: Methodologie van kostenonderzoek en referentieprijzen voor economische evaluaties in de gezondheidszorg. National Health Care Institute. 2015 Gregori D, Petrinco M, Bo S, Desideri A, Merletti F, Pagano E. Regression models for analyzing costs and their determinants in health care: an introductory review. Int J Qual Health Care. 2011;23:331–41. Keller MB, Shapiro RW, Lavori PW, Wolfe N. Recovery in major depressive disorder: analysis with the life table and regression models. Arch Gen Psychiatry. 1982;39:905–10. Spijker J, de Graaf R, Bijl RV, Beekman AT, Ormel J, Nolen WA. Duration of major depressive episodes in the general population: results from The Netherlands Mental Health Survey and Incidence Study (NEMESIS). Br J Psychiatry. 2002;181:208–13. Raven D, Jörg F, Visser E, Oldehinkel AJ, Schoevers RA. Time-to-treatment of mental disorders in a community sample of Dutch adolescents. A TRAILS study. Epidemiol Psychiatr Sci. 2017;26:177–88. Berto P, D’Ilario D, Ruffo P, Di Virgilio R, Rizzo F. Depression: cost-of-illness studies in the international literature, a review. J Ment Health Policy Econ. 2000;3:3–10. Van H, Kool M. Integrated treatment for patients with comorbid depression and personality disorders. Curr Opin Psychiatry. 2020;33:70–5. Verduijn J, Verhoeven JE, Milaneschi Y, Schoevers RA, van Hemert AM, Beekman ATF, Penninx BWJH. Reconsidering the prognosis of major depressive disorder across diagnostic boundaries: full recovery is the exception rather than the rule. BMC Med. 2017;15:215-017-0972-8 National Health Care Institute. In: Medicijnkosten.nl. https://www.medicijnkosten.nl. Accessed June, 11 2020.